Efficacy and safeness of tralokinumab in patients with atopic dermatitis who developed conjunctivitis under dupilumab: A case series
Gaetano Licata, Vittorio Tancredi, Elena Pezzolo, Ginevra Pertusi, Ersilia Tolino, Mariachiara Arisi, Alessio Gambardella
Abstract
The data that support the findings of this study are openly available in Pubmed and Liebertpub at: (1) https://doi.org/10.1080/17512433.2018.1449642; (2) https://doi.org/10.1111/jdv.17705; (3) https://doi.org/10.1111/ijd.16022; (4) https://doi.org/10.1080/09546634.2022.2153578; (5) https://doi.org/10.1089/derm.2022.0063; (6) https://doi.org/10.1111/bjd.19574; (7) https://doi.org/10.1097/ICO.0000000000003162; (8) https://doi.org/10.1111/bjd.20810.
Topics & Concepts
DupilumabMedicineAtopic dermatitisDermatologyDermatology and Skin DiseasesUrticaria and Related ConditionsAllergic Rhinitis and Sensitization